Lv1
88 积分 2024-07-05 加入
Identification of Noncovalent Small-Molecules from Virtual Screening Toward the Development of Potential KRAS Inhibitors
22天前
已完结
Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluation
2个月前
已完结
Ergothioneine as a functional nutraceutical: Mechanisms, bioavailability, and therapeutic implications
2个月前
已完结
From KRAS G12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
2个月前
已完结
Comparative genomic landscape of acquired resistance in pancreatic cancer treated with pan-RAS or KRASG12C inhibitors
2个月前
已关闭
Discovery of TNI-97 as a Highly Selective, Orally Bioavailable HDAC6 Inhibitor for the Treatment of Triple-Negative Breast Cancer
2个月前
已完结
Recent Advances in Synthetic Strategies and Agrochemical Activities of Isoxazoline Derivatives
2个月前
已完结
From KRAS G12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
3个月前
已完结
Optimization of Covalent 6-Cyanoquinazoline KRAS G12C Inhibitors for the Treatment of Solid Tumors
3个月前
已完结
Biological properties, synthetic pathways and anti-aging mechanisms of nicotinamide mononucleotide (NMN): Research progress and challenges
3个月前
已完结
皖公网安备34019202002308
